Fund Tracker India by Ishaan Dungarwal
Guide

Baroda BNP Paribas Health and Wellness Fund

Holdings for Oct 2026, changes against Sep 2026, from Baroda BNP Paribas Mutual Fund's monthly file.

Baroda BNP Paribas Health and Wellness Fund portfolio holdings, Oct 2026: 33 stocks, ₹463 cr in listed equity, from Baroda BNP Paribas Mutual Fund's monthly disclosure; changes by share count against Sep 2026.

Fund managers: Rohan Korde; Ankeet Pandya

Benchmark: BSE Healthcare Total Return Index · Riskometer: Very High · SEBI category, as filed: Sectoral/Thematic Fund - Pharma and Healthcare Theme ·

Source: AMFI scheme summary document

NAV

Baroda BNP Paribas Health and Wellness Fund - Direct Plan - Growth Option

Source: AMFI

₹11.332420 Nov 2026
AUM

average for July - September 2026, all plans.

Source: AMFI

₹511 crJuly - September 2026
Expense ratio

The scheme's yearly running cost as a % of its assets, taken out of the NAV a little each day. A regular plan costs more: it pays a distributor's commission.

Category median: direct 1.23 %, regular 2.40 % (174 schemes) · Regular costs ₹1,150 more a year per ₹1 lakh

Of this, the base expense ratio, the part SEBI caps: direct 1.12 %, regular 2.10 %. The rest is brokerage, transaction costs and statutory levies such as GST and STT, as AMFI's file lists them.

A year, as of 20 Nov 2026. Source: AMFI · Glossary: TER

Direct 1.55 %Regular 2.70 %
Equity held
₹463 cr33 stocks · Oct 2026
Equity, % of fund

As the AMC's file prints % of NAV. The top 10 stocks together: 59.9%.

97.0%top 10 stocks 59.9%

This month: Oct 2026

compared with Sep 2026 · by share count

Equity held vs NAV

The teal line is the scheme's equity at month end, from its portfolio file; the faint line is the plan's NAV. Equity held moves with prices and with money in or out, the NAV with prices only.

last 12 months to Oct 2026
Nov 2025: equity held ₹592 cr, 28 stocks, NAV ₹9.74Dec 2025: equity held ₹560 cr, 27 stocks, NAV ₹9.55Jan 2026: equity held ₹528 cr, 28 stocks, NAV ₹9.16Feb 2026: equity held ₹541 cr, 29 stocks, NAV ₹9.69Mar 2026: equity held ₹494 cr, 32 stocks, NAV ₹9.23Apr 2026: equity held ₹516 cr, 35 stocks, NAV ₹9.59May 2026: equity held ₹530 cr, 33 stocks, NAV ₹10.02Jun 2026: equity held ₹542 cr, 31 stocks, NAV ₹10.45Jul 2026: equity held ₹502 cr, 30 stocks, NAV ₹10.98Aug 2026: equity held ₹501 cr, 33 stocks, NAV ₹11.12Sep 2026: equity held ₹473 cr, 33 stocks, NAV ₹10.71Oct 2026: equity held ₹463 cr, 33 stocks, NAV ₹10.81
% change and month by month (tables)
% change to Oct 2026
OverSinceEquity heldNAV
3 monthsJul 2026▼ −7.8%▼ −1.5%
6 monthsApr 2026▼ −10.3%▲ +12.7%
12 monthsOct 2025▼ −22.0%▲ +11.3%
MonthEquity heldStocksNAV at month end
Nov 2025₹592 cr28₹9.7403
Dec 2025₹560 cr27₹9.5498
Jan 2026₹528 cr28₹9.1595
Feb 2026₹541 cr29₹9.6899
Mar 2026₹494 cr32₹9.2295
Apr 2026₹516 cr35₹9.5893
May 2026₹530 cr33₹10.0199
Jun 2026₹542 cr31₹10.4472
Jul 2026₹502 cr30₹10.9769
Aug 2026₹501 cr33₹11.1230
Sep 2026₹473 cr33₹10.7052
Oct 2026₹463 cr33₹10.8071
Oct 2026 · Sources: AMC monthly portfolio (SEBI disclosure); AMFI NAV files · How to read

Moves, Oct 2026

How many stocks the scheme bought into, added to, cut or sold out of this month, by share count, so a price move alone never counts.

vs Sep 2026
  • New1
  • Added2
  • Trimmed11
  • Exited1
Stocks, by share count · Source: Baroda BNP Paribas Mutual Fund monthly portfolios Report a wrong number

Asset mix, Oct 2026

How much of the fund sits in listed shares; the rest is foreign shares, debt, money market, cash and other assets.

% of fund
  1. Listed equity
    97.0%
  2. Rest, not itemised
    3.0%
Source: Baroda BNP Paribas Mutual Fund monthly portfolio

Rest = foreign shares, debt, money market, cash, REIT/InvIT units and other assets.

Sectors and top 10, Oct 2026

Sector mix, Oct 2026

How the scheme's equity is spread across sectors at month end.

% of equity held
Source: Baroda BNP Paribas Mutual Fund monthly portfolio; AMFI

AMFI's 22 sectors; one sector per stock, from the fund houses' industry labels.

Report a wrong number

Large, mid and small cap, Oct 2026

How the scheme's equity splits across large, mid and small companies, on AMFI's list.

% of equity held
  1. Mid Cap
    46.3%
  2. Large Cap
    33.1%
  3. Small Cap
    16.1%
  4. Not in AMFI's list
    4.4%
Source: Baroda BNP Paribas Mutual Fund monthly portfolio; AMFI

AMFI's list of Jun 2026.

Report a wrong number

Top 10 holdings

Its ten largest stocks, each as a share of the fund.

% of fund · 59.9% together
Source: Baroda BNP Paribas Mutual Fund monthly portfolio

As the AMC's file prints % of NAV.

Changes, Oct 2026 vs Sep 2026

Every stock whose share count changed: new, added, trimmed, exited.

15 stocks · by share count
StockChangeShares beforeShares nowDifferenceChange %Value of changeValue now
PARASHLTH New—98,541+98,541—+₹7.3 cr₹7.3 cr
GLAXO Added12,00015,000+3,000+25.0%+₹0.75 cr₹3.7 cr
LICI Added57,67582,675+25,000+43.3%+₹0.96 cr₹3.2 cr
IPCALAB Trimmed1.55 lakh1.50 lakh−5,000−3.2%−₹0.96 cr₹28.9 cr
AUROPHARMA Trimmed90,00082,000−8,000−8.9%−₹1.3 cr₹13.8 cr
LALPATHLAB Trimmed85,00070,000−15,000−17.6%−₹2.9 cr₹13.3 cr
ASTRAZEN Trimmed22,00018,000−4,000−18.2%−₹2.5 cr₹11.5 cr
ACUTAAS Trimmed35,00027,000−8,000−22.9%−₹3.2 cr₹10.8 cr
ABBOTINDIA Trimmed4,5004,000−500−11.1%−₹1.3 cr₹10.3 cr
MANKIND Trimmed65,00040,000−25,000−38.5%−₹6.2 cr₹10.0 cr
ASTERDM Trimmed1.50 lakh1.40 lakh−10,000−6.7%−₹0.68 cr₹9.5 cr
CONCORDBIO Trimmed75,00070,000−5,000−6.7%−₹0.62 cr₹8.7 cr
EMCURE Trimmed60,00040,000−20,000−33.3%−₹3.7 cr₹7.5 cr
METROPOLIS Trimmed1.20 lakh1.10 lakh−10,000−8.3%−₹0.55 cr₹6.0 cr
PGHL Exited1,533—−1,533—−₹0.85 cr₹0.85 cr
Source: Baroda BNP Paribas Mutual Fund monthly portfolios

Value of change = the difference in shares × this month's price in the AMC's file. Value now = the whole holding's market value in that file (an exit: last month's).

How to read

Report a wrong number

Full portfolio, Oct 2026 (33 stocks)

Every listed stock in the month's file, largest first.

largest first, by value
Company Sector
SUNPHARMASun Pharmaceutical Industries Limited Healthcare2.30 lakh₹40.9 cr8.58%
DIVISLABDivi's Laboratories Limited Healthcare41,000₹40.1 cr8.41%
TORNTPHARMTorrent Pharmaceuticals Limited Healthcare80,000₹36.9 cr7.74%
LAURUSLABSLaurus Labs Limited Healthcare1.50 lakh₹36.1 cr7.56%
IPCALABIPCA Laboratories Limited Healthcare1.50 lakh₹28.9 cr6.06%
LUPINLupin Limited Healthcare1.39 lakh₹28.0 cr5.86%
APOLLOHOSPApollo Hospitals Enterprise Limited Healthcare31,500₹26.6 cr5.58%
FORTISFortis Healthcare Limited Healthcare2.52 lakh₹19.4 cr4.06%
GLENMARKGlenmark Pharmaceuticals Limited Healthcare65,000₹14.9 cr3.13%
AUROPHARMAAurobindo Pharma Limited Healthcare82,000₹13.8 cr2.89%
LALPATHLABDr. Lal Path Labs Limited Healthcare70,000₹13.3 cr2.80%
ZYDUSLIFEZydus Lifesciences Limited Healthcare94,000₹11.7 cr2.45%
ASTRAZENAstraZeneca Pharma India Limited Healthcare18,000₹11.5 cr2.40%
ACUTAASAcutaas Chemicals Limited Healthcare27,000₹10.8 cr2.27%
ABBOTINDIAAbbott India Limited Healthcare4,000₹10.3 cr2.15%
MANKINDMankind Pharma Limited Healthcare40,000₹10.0 cr2.09%
ASTERDMAster DM Quality Care Limited Healthcare1.40 lakh₹9.5 cr2.00%
MFSLMax Financial Services Limited Financial Services78,498₹9.4 cr1.97%
CONCORDBIOConcord Biotech Limited Healthcare70,000₹8.7 cr1.83%
SYMBIOTECSymbiotec Pharmalab Limited Healthcare60,720₹7.6 cr1.59%
EMCUREEmcure Pharmaceuticals Limited Healthcare40,000₹7.5 cr1.57%
AJANTPHARMAjanta Pharma Limited Healthcare21,000₹7.4 cr1.54%
PARASHLTHParas Healthcare Limited Healthcare98,541₹7.3 cr1.53%
DRREDDYDr. Reddy's Laboratories Limited Healthcare50,000₹6.8 cr1.42%
NEPHROPLUSNephrocare Health Services Ltd. Healthcare1.05 lakh₹6.5 cr1.35%
GLANDGland Pharma Limited Healthcare20,000₹6.2 cr1.30%
METROPOLISMetropolis Healthcare Limited Healthcare1.10 lakh₹6.0 cr1.26%
MANIPALHOSManipal Health Enterprises Ltd Healthcare84,750₹5.7 cr1.19%
CIPLACipla Limited Healthcare40,000₹5.5 cr1.16%
NHNarayana Hrudayalaya Limited Healthcare26,500₹4.6 cr0.96%
IKSInventurus Knowledge Solutions Limited Information Technology25,000₹4.3 cr0.89%
GLAXOGlaxosmithkline Pharmaceuticals Ltd. Healthcare15,000₹3.7 cr0.78%
LICILife Insurance Corporation Of India Financial Services82,675₹3.2 cr0.66%
Show all 33 stocksShow the first 15

Equity rows as disclosed, Oct 2026. Source: Baroda BNP Paribas Mutual Fund monthly portfolio. Report a wrong number

Large, mid and small caps, % of net assets, last 12 months

AMFI list in force each month
MonthLargeMidSmallNot in AMFI's listAMFI list
Oct 202632.1%44.9%15.7%4.3%Jun 2026
Sep 202631.1%45.1%18.1%2.7%Jun 2026
Aug 202632.0%44.4%19.9%2.5%Jun 2026
Jul 202630.5%43.7%21.4%1.0%Jun 2026
Jun 202628.7%38.9%30.5%0.0%Dec 2025
May 202628.4%37.6%31.4%0.0%Dec 2025
Apr 202626.7%36.3%34.3%0.0%Dec 2025
Mar 202629.2%32.4%34.3%0.0%Dec 2025
Feb 202634.7%27.5%33.6%0.0%Dec 2025
Jan 202633.8%30.6%32.5%0.0%Dec 2025
Dec 202546.9%21.0%27.2%0.3%Jun 2025
Nov 202548.1%20.4%28.2%0.0%Jun 2025
Sources: Baroda BNP Paribas Mutual Fund monthly portfolios; AMFI. How to read

Equity holdings' % of net assets each month, by AMFI's cap list in force that month.

Portfolio turnover, from holdings

equity only · month-end snapshots
Turnover, 12 months65.8%Oct 2025 to Oct 2026 · bought ₹346 cr, sold ₹535 cr
MonthBoughtSoldTurnover
Oct 2026₹9.0 cr₹24.9 cr1.9%
Sep 2026₹5.5 cr₹14.8 cr1.1%
Aug 2026₹12.3 cr₹19.7 cr2.4%
Jul 2026₹17.3 cr₹83.5 cr3.3%
Jun 2026₹46.6 cr₹57.7 cr8.7%
May 2026₹24.0 cr₹33.0 cr4.6%
Apr 2026₹43.4 cr₹41.1 cr8.1%
Mar 2026₹40.1 cr₹62.3 cr7.7%
Feb 2026₹46.5 cr₹65.9 cr8.7%
Jan 2026₹26.4 cr₹35.4 cr4.9%
Dec 2025₹38.5 cr₹57.9 cr6.7%
Nov 2025₹36.3 cr₹39.2 cr6.1%
Source: Baroda BNP Paribas Mutual Fund monthly portfolios. How to read

The lower of bought and sold over the average equity value, from month-end holdings; it can differ from the fund house's own figure.

Returns next to the benchmark

What the plan's NAV did over each period, as AMFI publishes it.

as of 19 Nov 2026 · as published by AMFI
PeriodDirect planRegular planBenchmark, as published by AMFI BSE Healthcare TRI
1 year+15.99 %+14.15 %+19.11 %
Since launch+8.73 %+6.93 %+14.74 %

Past performance may not be sustained in future.

Source: AMFI fund performance

As AMFI's fund performance report prints them for "Baroda BNP Paribas Health and Wellness Fund"; this site computes no benchmark figure of its own.

How to read

How it is computed: NAV to NAV

Baroda BNP Paribas Health and Wellness Fund - Direct Plan - Growth Option: these run to the newest NAV stored (20 Nov 2026) and are computed here from AMFI's NAV files; AMFI's figures above run to 19 Nov 2026, so the two differ by the days in between.

PeriodReturnFromTo
1 year+16.91 % in total 20 Nov 2025 · NAV ₹9.693220 Nov 2026 · NAV ₹11.3324
Since first NAV+9.32 % a year, compounded 1 Jul 2025 · NAV ₹10.012620 Nov 2026 · NAV ₹11.3324

Source: AMFI NAV files (plan code 153604). How to read Report a wrong number

Not enough NAV history stored yet for rolling returns and calendar-year returns.

IDCW (dividend) history

0 declarations · as of 3 Nov 2026 · Source: AMFI
AMFI lists no IDCW declared by this scheme.
Source: AMFI scheme dividends. How to read

IDCW (formerly "dividend") declared per unit of each IDCW plan, as AMFI lists it.

Volatility, a year

Standard deviation of weekly NAV changes × √52. 4 Jul 2025 to 20 Nov 2026, 72 weekly changes.

Source: AMFI

13.07 %72 weeks to 20 Nov 2026
Largest fall from a high

High 25 Jul 2025, low 2 Apr 2026; back at the high 22 May 2026.

Weekly NAVs since 4 Jul 2025. Measured on each week's last NAV, so a fall within a week can be deeper than shown.

Source: AMFI

−10.20 %low 2 Apr 2026

Past performance may not be sustained in future.

Next to its category: Sectoral or thematic

weekly NAVs · Source: AMFI

From each quarter end to the newest NAV

FromDatesThis schemeCategory average
From Jun 202625 Jun 2026 to 20 Nov 2026 in total+9.9 %+4.6 % 195 schemes
From Mar 202627 Mar 2026 to 20 Nov 2026 in total+21.3 %+18.1 % 195 schemes
From Dec 202526 Dec 2025 to 20 Nov 2026 in total+18.9 %+6.9 % 188 schemes
From Sep 202526 Sep 2025 to 20 Nov 2026 a year, compounded+16.4 %+9.0 % 182 schemes
Spread of falling weeks, a year

Root mean square of the weekly falls × √52 (rising weeks count as zero).

8.2 %4 Jul 2025 to 20 Nov 2026
Up capture

Its average change in the 37 weeks the category average rose, as a share of the category's.

88.5 %37 rising weeks
Down capture

The same for the 35 weeks the category average fell.

77.1 %35 falling weeks

Past performance may not be sustained in future.

Source: AMFI NAV files.

Category average = the plain average for the other schemes in the same AMFI category with the same figure (direct growth plans, each week's last NAV). It is not an index, and the scheme's place among them is not shown. Peers are today's schemes in today's category, so a scheme that has closed is not in the average, and SEBI re-sorted the categories in 2018.

52-week high NAV

Highest and lowest of 248 daily NAVs, 20 Nov 2025 to 20 Nov 2026, Baroda BNP Paribas Health and Wellness Fund - Direct Plan - Growth Option.

Source: AMFI

₹11.36739 Nov 2026
52-week low NAV₹9.059429 Jan 2026

Monthly SIP of ₹10,000, Baroda BNP Paribas Health and Wellness Fund - Direct Plan - Growth Option

XIRR · Source: AMFI
PeriodInstalmentsPaid inValueXIRR, a year
1 year 1 Dec 2025 to 2 Nov 202612 ₹1,20,000₹1,35,594 20 Nov 2026 · NAV ₹11.3324+26.49 %

Past performance may not be sustained in future.

Source: AMFI NAV files. How to read

₹10,000 on the first NAV of each month, valued at the newest NAV; no stamp duty, exit load or tax taken off.

Embed this card

Card for this scheme: facts with source and date

Copy this into any web page. The image carries its source, date and a link back; it is redrawn each night.

Portfolios most like this one, Oct 2026

same category, other fund houses
Most alike and most unique funds →

Overlap is the sum, over stocks both hold, of the smaller of the two weights. A measured likeness, not a suggestion to switch.

From AMFI's own files (scheme summary documents, NAV history, TER), as they stood on the day shown.

Questions about Baroda BNP Paribas Health and Wellness Fund

from the figures on this page

What are the top holdings of Baroda BNP Paribas Health and Wellness Fund?

At Oct 2026 end, Baroda BNP Paribas Health and Wellness Fund held 33 stocks (97.0% of the fund in equity). Largest: Sun Pharmaceutical Industries 8.58%, Divi's Laboratories 8.41%, Torrent Pharmaceuticals 7.74%, Laurus Labs 7.56%, IPCA Laboratories 6.06%; the top 10 make up 59.9%. Funds holding Sun Pharmaceutical Industries · Funds holding Divi's Laboratories · Funds holding Torrent Pharmaceuticals

What portfolio changes did Baroda BNP Paribas Health and Wellness Fund make in Oct 2026?

Compared with Sep 2026, by share count: 1 new, 2 added, 11 trimmed, 1 exited. Largest by value: Paras Healthcare (new), Glaxosmithkline Pharmaceuticals (added), Life Insurance Corporation Of India (added), IPCA Laboratories (trimmed).

Who manages Baroda BNP Paribas Health and Wellness Fund?

AMFI's scheme summary document names Rohan Korde, Ankeet Pandya for Baroda BNP Paribas Health and Wellness Fund (Baroda BNP Paribas Mutual Fund). Rohan Korde, fund manager portfolio · Ankeet Pandya, fund manager portfolio

All schemes of Baroda BNP Paribas Mutual Fund →

Mutual fund investments are subject to market risks; read all scheme related documents carefully.